Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project

• Conditions: Hypertension; Diabetes Mellitus

• Registration Number: NCT04229628
• Lead Sponsor: Guangdong Provincial People's Hospital

Brief Summary

To develop and implement quality improvement programs for the treatment and management of hypertension and diabetes,and preventing and controlling hypertension and diabetes-related diseases in Chinese community. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of hypertension and diabetes in Chinese community.

Detailed Description

The aim of this project was to improving care for hypertension and diabetes mellitus in Chinese community. Study population including subjects who are hypertension and/or diabetes mellitus, of any race or ethnicity, any age.

Study Timeline

• Status Verified: 2019-12
• Study Start: 2020-01-01
• Study First Submitted: 2020-01-12
• Study First Submitted QC: 2020-01-12
• Last Update Submitted: 2020-01-12
• Study First Posted: 2020-01-18
• Last Update Posted: 2020-01-18
• Primary Completion: 2020-12-31
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100000

Inclusion Criteria

• In accordance with the diagnosis of essential hypertension;
• In accordance with the diagnosis of type 2 diabetes mellitus.

Exclusion Criteria

• Non-type 2 diabetes patients
• Secondary hypertension
• Non-hypertensive patients
• Type 1 diabetes or other types of diabetes

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommended	at the time of enrollment	Proportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommended at the time of enrollment
Proportion of community hypertension patients receiving treatment as Chinese guideline recommended	at the time of enrollment	Proportion of community hypertension patients receiving treatment as Chinese guideline recommended at the time of enrollment

Trial Locations

Locations (1)

Guangdong Provincial People's Hospital; 🇨🇳 Guangzhou, Guangdong, China